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a b s t r a c t
Foot-and-mouth disease virus (FMDV) is a signiﬁcant economically and distributed globally pathogen of
Artiodactyla. Current vaccines are chemically inactivated whole virus particles that require large-scale
virus growth in strict bio-containment with the associated risks of accidental release or incomplete inac-
tivation. Non-infectious empty capsids are structural mimics of authentic particles with no associated
risk and constitute an alternate vaccine candidate. Capsids self-assemble from the processed virus struc-
tural proteins, VP0, VP3 and VP1, which are released from the structural protein precursor P1-2A by the
action of the virus-encoded 3C protease. To date recombinant empty capsid assembly has been limited by
poor expression levels, restricting the development of empty capsids as a viable vaccine. Here expression
of the FMDV structural protein precursor P1-2A in insect cells is shown to be efﬁcient but linkage of therotein processing
rameshift
C protease
accine
cognate 3C protease to the C-terminus reduces expression signiﬁcantly. Inactivation of the 3C enzyme in
a P1-2A-3C cassette allows expression and intermediate levels of 3C activity resulted in efﬁcient process-
ing of the P1-2A precursor into the structural proteins which assembled into empty capsids. Expression
was independent of the insect host cell background and leads to capsids that are recognised as authentic
by a range of anti-FMDV bovine sera suggesting their feasibility as an alternate vaccine.. Introduction
Foot-and-mouth disease virus (FMDV) is the prototypic aph-
hovirus within the family Picornaviridae (reviewed by (Grubman
nd Baxt, 2004)). Economic losses from foot-and-mouth disease
utbreaks are among the highest of all livestock diseases and
idespread vaccination is the method of choice for disease con-
rol (Rodriguez and Grubman, 2009). The current vaccine is a killed
hole virus vaccinewhose limitations have beenwidely discussed;
rowth of the live virus prior to inactivation is not without risk,
he appropriate serotype for each outbreak is required, some ﬁeld
trains grow poorly before adaptation and immunogenicity can be
∗ Corresponding author.
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lost upon storage (Rodriguez andGrubman, 2009). To address these
issues alternate vaccines have been sought, among them the use of
empty capsids which are structural and immunogenic mimics of
virus particles but lack the potential for causing disease outbreak
(Rowlands et al., 1975; Rweyemamu et al., 1979).
As for all picornaviruses, the icosahedral FMDV capsid is assem-
bled from mature proteins derived from a structural precursor,
P1-2A, following cleavage in trans by the 3C protease (reviewed by
(Belsham, 2005)). The 3C protease is one of many non-structural
proteins synthesised in the infected cell but expression of P1-
2A and 3C in the absence of any other FMDV encoded protein
in recombinant systems is sufﬁcient to afford authentic precur-
Open access under CC BY license.sor cleavage (Lewis et al., 1991; Roosien et al., 1990). Accordingly
there have been a number of reports of the assembly of recombi-
nant FMDV empty capsids following the use of expression systems
such as vaccinia virus (Abrams et al., 1995), adenovirus (Mason
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made use of standard protocols or, when kits were used, those
recommended by the vendor. All vectors were conﬁrmed by DNA
sequencing prior to use for expression.
Fig. 1. Expression screening of various FMDV P1-2A±3C cassettes. (A) Cartoon rep-
resentation of the genetic designs tested. The text near the bottom right representsC. Porta et al. / Journal of Virol
t al., 2003), E. coli (Cao et al., 2010; Lewis et al., 1991), transgenic
lants (Pan et al., 2008) and baculovirus (Li et al., 2008; Oem et al.,
007; Roosien et al., 1990). In some cases, sufﬁcient empty cap-
id material has been prepared to immunise cattle and protection
gainst homologous challenge was demonstrated (Li et al., 2008,
011) but in the main the conﬁguration of the P1and 3C coding
equences used to achieve empty capsid expression and the efﬁ-
iency of capsid assembly has been highly variable, particularly in
nsect cells. For example, using the successful expression of swine
esicular disease empty capsids as an exemplar (Ko et al., 2005),
sage of a dual promoter vector in which the P1 and 3C coding
equences of an O serotype of FMDV were under the control of the
aculovirus polyhedrin and p10 promoters respectively, resulted
n incomplete precursor cleavage and predominantly pentameric
ssemblies rather than complete capsids (Oem et al., 2007). Simi-
arly, a dual expression strategy of an Asia 1 serotype of FMDV led
o incomplete cleavage of the P1-2A precursor (Cao et al., 2009).
ore recently, forsaking the use of 3C to generate the mature cap-
id proteins, VP0 and VP3-2A-VP1 from an O serotype of FMDV
ere co-expressed relying on self-cleavage at the 2A site (Donnelly
t al., 2001) to generate the requisite structural proteins for assem-
ly, which resulted in partial success (Cao et al., 2010). In a further
xample, a Bombyx (silk worm) baculovirus system encoding a
1-2A-3C sequence of an FMDV Asia 1 isolate was used as a sin-
le transcription unit driven by the polyhedrin promoter and the
mpty capsid material harvested from the haemolymph of the
nfected silk worms was immunogenic in cattle and led to lev-
ls of neutralising antibody associated with protection (Li et al.,
008, 2011). Despite these successes, variation associated with
oth the FMDV serotype and the host cell background used mean
hat a uniform genetic design capable of producing empty cap-
ids for any serotype has yet to be reported. Recently, the yield
f empty capsids from insect cells for another picornavirus, human
nterovirus 71,was improved by use of a dual vector inwhich a less
ctive promoter, the CMV early promoter, was used for transcrip-
ion of the 3C coding unit whilst the strong polyhedrin promoter
irected expression of the P1 structural precursor (Chung et al.,
010). However, yield improvement was restricted to Sf9 cells as
nfection of T.ni cells, an alternative insect cell line that generally
ives higher expression levels (Davis et al., 1993), resulted in poor
apsid expression plausibly as a result of low levels of promoter-
peciﬁc transcription factors present in T.ni cells. Picornaviruses
raditionally exhibit a strong “host cell shutoff” phenotype which
s partly the result of 3C protease cleavage of host cell proteins in
ddition to its action on the virus structural precursor P1 (Li et al.,
001; Strong and Belsham, 2004). As a result, picornavirus repli-
ation cycles are typically rapid and exhibit extensive cytopathic
ffect (e.g. (Rodriguez Pulido et al., 2007)). It follows that if cleav-
ge of host cell proteins by FMDV 3C protease was to occur in a
ecombinant empty capsid expression system it would curtail the
xpression period and limit the yield of capsids observed. Thus,
ariable levels of 3C expression could account for the variation in
he levels of FMDV empty capsids reported to date and purpose-
ul moderation of 3C activity might enhance the yield of capsid
bserved, allowing a more thorough exploration of their virtues
s vaccine candidates. Here a new genetic design is described for
he expression of empty FMDV capsids in insect cells following
nfection by recombinant baculoviruses expressing P1-2A-3C with
number of modiﬁcations to reduce 3C activity.
. Materials and methods.1. Cell culture and virus growth
Sf9, T.ni and T.nao38 cells were cultured in BioWhittaker®
nsect-Xpress (Lonza, Basel, Switzerland) supplemented with 2%Methods 187 (2013) 406–412 407
FCS, 100units/ml penicillin, 100g/ml streptomycin and2.5g/ml
amphotericin B. Cells were grown at 28 ◦C as monolayers or in sus-
pension with agitation at 100 rpm. Baculoviruses were generally
ampliﬁed in monolayer cultures but large scale infections for cap-
sid isolation were done in suspension. Virus stocks were titreed
using plaque assay on Sf9 monolayers.
2.2. Sequences and cloning
The sequence for FMDV A22 Iraq (AY593764.1) was that
deposited in the database. DNA was synthesised de novo (Lifetech-
nologies, Carlsbad,USA). The transfer vectorused for all expressions
was based on pOPINE (Berrow et al., 2007), itself a derivative of
pTriEx1.1 (EMD Biosciences, Billerica, USA) and a fragment encod-
ing P1-2A-3C of FMDV serotype A22was cloned downstreamof the
p10 promoter by use of In-Fusion Technology (Clontech, Moun-
tain View, USA). Mutations within this cassette were introduced
by the swapping of appropriate fragments via unique restriction
sites introduced during gene synthesis. Recombination between
pOPINE vectors and AcMNPV bacmid KO1629 in insect cells was
as described (Zhao et al., 2003). Routine DNA procedures in vitrothe amino acid sequence of FMDV 3C between residues 141–170 with Cys 142 and
Cys 163 highlighted. (B) Outcome of screening the various A22 Iraq constructs by
immunoblottingusingapolyvalentAserum.TheexpectedmigrationpositionsofP1-
2A-3C, P1-2AandVP1are indicated althoughvery little P1-2A-3C is visible.Numbers
to the left are the migration positions of protein markers and are in kilodaltons.
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.3. Electrophoresis and Western blotting
Protein samples were separated on pre-cast 10% Tris–HCl SDS-
olyacrylamide gels (BioRad, Berkeley, USA) and transferred to
mmobilon-P membranes (Millipore, Billerica, USA) using a semi-
ry blotter. For 10-well gels each sample loaded represented
×104 cells. Following transfer, ﬁlterswere blocked for 1h at room
emperature using PBS containing 0.1% v/v Tween-20 (PBS-T), 5%
/v milk powder. Primary antibodies were used at 1g/ml or at a
ilution of 1:1000 in PBS-T, 5% w/vmilk powder. Following several
asheswith PBS-T, themembraneswere incubated for 1hwith the
ppropriate HRP-conjugates and the bound antibodies detected by
M chemiluminescence (Roche, Basel, Switzerland).
.4. Puriﬁcation of empty capsidsInfected cultures (typically ∼109 cells) were harvested at 3days
i. and lysed by resuspension in 1/20th of the original volume of
% Triton X-100 in PBS and held at 4 ◦C for 30min with occasional
ig. 2. Cartoon representation of the vector used for expression of empty FMDV capsids w
f the capsid polyprotein precursor coding region from different serotypes are indicated
nd the junctions between them. The frameshift event, which begins on the overlapping P
ndicated by the dotted line. (C) Sequence detail of the HIV frameshift (above) and its relaMethods 187 (2013) 406–412
agitation. Unbroken cells and nuclei were removed by centrifuga-
tion (4500 rpm, 15min) and the clariﬁed lysate layered onto a 30%
sucrose (w/v in PBS) cushion. After centrifugation at 100,000× g for
100min the supernatantwas discarded and the pellet resuspended
in 1/10 tube volume of PBS containing 3500units of benzonase.
After 30min at room temperature, the solution was clariﬁed and
applied to a preformed discontinuous 30–60% sucrose (w/v in PBS)
gradient made up by seven increments of 5%. The gradient was
developedbycentrifugationat100,000× g for16hand fractionated
from the top.
2.5. Assessing capsid antigenicity
Assays to measure the reactivity of recombinant empty cap-
sids with a range of FMDV serotype speciﬁc polyclonal antisera
were performed in a competitive ELISA format as described (Li
et al., 2012). Data were expressed as percentage inhibition scores
compared to an OIE standard antigen preparation. Statistical sig-
niﬁcance was assessed by one-way analysis of variance (ANOVA).
ith the salient features shown. Unique restriction sites available for the exchange
by red boxes. (B) Translated ORF details of the P1-2A polyprotein, the 3C protease
he residue and results in a single polyprotein linking the P1-2A and 3C proteins, is
tionship to the translated product (below).
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.6. Electron microscopy
Samples were allowed to adhere to carbon coated formvar grids
or 5min at room temperature followed by a brief water wash
1min) before staining with 1% uranyl acetate for 1min. Excess
tain was removed by blotting and the grids examined on a Philips
M20 (Philips Electronics, Amsterdam, Netherlands) operating at
0 kV.
. Results
Preliminary experiments with constructs (Fig. 1A) encoding the
reviously deﬁned minimum proteins for FMDV capsid protein
xpression and cleavage (Lewis et al., 1991; Roosien et al., 1990)
ased on a synthetic sequence of FMDV A22 Iraq revealed that
xpression of P1-2A led to the abundant synthesis of FMDV-related
ntigenof theexpectedmolecularweight (∼90kDa)aswell as some
on-speciﬁcdegradationproducts,whilst fusionof3C inphasewith
he C terminus of P1-2A effectively abolished expression (Fig. 1B).
hen the sameexpression cassette included a site-directed change
f the 3C active site cysteine 163 to alanine (Sweeney et al., 2007),
xpression of a protein of the molecular weight of P1-2A fused to
C (a minor product) in addition to P1-2A (the predominant prod-
ct) (∼110kDa and ∼90kDa, respectively) was observed (Fig. 1B).
hus, 3C activity and not a cis acting sequence acts to restrict P1-
A expression. As a lower 3C activity might be compatible with an
nzyme level sufﬁcient to allow P1-2A expression and subsequent
leavage, expression cassettes were designed to reduce 3C activ-
ty. Two approaches were used: site-directed mutagenesis of 3C,
ased on the three-dimensional structure of the enzyme, that had
reviously been shown to reduce enzyme activity in vitro (Sweeney
t al., 2007), and the introduction of theHIV-1 ribosomal frameshift
ite, which has been shown to function in insect cells (Adamson
t al., 2003), between the P1-2A and 3C coding sequences (Fig. 1A).
xpression screening revealed that individual changes at3C residue
42 led to the detection of a band at ∼26kDa consistent with the
ig. 3. Time course of expression of FMDV A22 antigen in three insect cell lines. Numbers
xception of track 1 which is the mock infected control. In panel A, the serum used for im
or Animal Health). Panel B is an infection control using a monoclonal antibody to the bac
f protein markers and are in kilodaltons.Methods 187 (2013) 406–412 409
expectedmolecularweight of themature VP1 product following 3C
cleavage of the P1-2A precursor protein. A combination of both the
frameshift and the 3C Cys142Thr mutation was the most produc-
tive approach leading to almost complete processing of P1-2A as
monitored by the appearance of VP1 (Fig. 1B). The serum used for
the Western blot detection of FMDV proteins was polyvalent but
reactivity was largely directed to epitopes in VP1. However, some
reactivity with intermediates (e.g. VP3-VP1) in the cleavage reac-
tion is apparent. In addition, the resulting optimised vector allows
exchange of the FMDV P1-2A coding region via unique restriction
sites (Fig. 2A) permitting any FMDV capsid serotype to be juxta-
posed to the moderated 3C translation product (Fig. 2B).
A feature of the expression design described here, which differs
from most previous examples, is that only one transcription unit
is present, in this case driven by the AcMNPV p10 promoter and
control of 3C expression is achieved wholly at the level of trans-
lation. Previous examples of high level picornavirus expression
with moderated 3C activity have used different promoters but
exhibited strong host cell variability (Chung et al., 2010). To assess
expression in a variety of insect cells, a high titre baculovirus
stock of the optimal A22 P1-2A-FS-3C-C142T construct was used
to infect Spodoptera frugiperda (Sf9) and two Trichoplusia ni (T.ni
and T.nao38) cell lines and a time course of FMDV antigen expres-
sion was conducted. Sf9 cells are widely used for recombinant
baculovirus work but T.ni lines have been shown to give higher
expression levels in some cases (Hashimoto et al., 2010, 2012;
Maruniak et al., 1994). FMDV VP1 antigen was apparent at 2days
post infection in all lines tested with peak levels occurring at
3 and 4days post infection (Fig. 3A) typical of baculovirus very
late promoter driven expression (Loureiro et al., 2011; Pengelley
et al., 2006). Little unprocessed P1-2A was observed suggesting
that expression and cleavage are tightly coupled, as expected of
a polyprotein and protease translated from a single mRNA. Both
T.ni cell lines expressed higher levels of FMDV antigen when
compared to Sf9 cells on a volume equivalent basis with the rank
order, based on VP1 band intensity, being T.nao38>T.ni > >Sf9.
above the track are days post infection in each of the cell lines indicated, with the
munodetection was a Guinea pig polyvalent A serotype (a reagent of the Institute
ulovirus surface glycoprotein gp64. Numbers to the left are the migration position
410 C. Porta et al. / Journal of Virological
Fig. 4. Analysis of empty capsid assembly. (A) Sucrose gradient fractionation of
FMDV capsidmaterial analysed byWestern blot usingA22 serotype antiserawith an
extract of A22 recombinant virus infectedSf9 cells. Numbers at the top are fractions
n
i
i
D
r
b
g
c
p
i
p
a
o
f
f
l
s
2
(
i
h
t
w
s
m
pumbers. Numbers to the left are the migration position of protein markers and are
n kilodaltons. (B) Peak fractions from the gradient were analysed by TEM. The bar
s 100nm.
ifferences in signal intensity in the different cell lines did not
elate to levels of baculovirus infection as Western blotting for a
aculovirus encoded protein, the major structural glycoprotein
p64, showed similar levels of infection (Fig. 3B). In addition, one
ommercial cell line, VE cells, in which a viral ankaryn repeat
rotein from Campoletis sonorensis ichnovirus has been integrated
nto the Sf9 genome to reduce levels of AcMPNV-induced apo-
tosis (Fath-Goodin et al., 2009) was tested but they offered no
dvantage when compared to unmodiﬁed Sf9 cells (unpublished
bservations). Based on the results obtained analogous constructs
or the seven FMDV serotypes should express similarly although
urther engineering may be required to optimise the expression
evel of any one sequence.
Cleavage of the FMDV P1-2A precursor protein into mature
tructural proteins can lead to empty capsid assembly (Cao et al.,
009, 2010) although incomplete assembly has also been observed
Oem et al., 2007). To test for the production of empty capsids
n the system described here, extracts of infected insect cells
arvested at 3days post infection were clariﬁed by low speed cen-
rifugation and the particulate material present in the supernatant
as collected by sedimentation through a 30% sucrose cushion and
ubsequently on a sucrose velocity gradient. Fractions from the
iddle of the gradient (∼40% sucrose), typically the sedimentation
osition of intact empty capsids, were positive for VP1 by WesternMethods 187 (2013) 406–412
blot (Fig. 4A). Electron microscopy of the same fractions revealed
uniform structures typical of picornavirus capsids with stain
penetration consistent with empty capsid assembly (Fig. 4B).
To ensure the empty capsids observedwere authentic structural
mimics of FMDV particles they were compared with inactivated
FMDV grown in BHK21 cells in a sandwich ELISA format using a
number of interrogating sera (Li et al., 2012). Of 38 different bovine
sera, representing seroconversion to infection or vaccination with
serotype A virus or vaccine, no signiﬁcant differences (P<0.001)
wereobservedbetween theperformanceof the recombinantempty
capsids and themoreestablishedvirus antigen source (Fig. 5). These
data suggest that the recombinant empty capsids are faithful mim-
ics of authentic virus, at least to the level probed by the antibodies
used here. Puriﬁed empty FMDV capsids expressed in insect cells
raised neutralising antibodies in guinea-pigs as measured by two
OIEprescribed tests for thepresenceof speciﬁcantibodies: thevirus
neutralisation test (VNT) and the liquidphaseblockingELISA (LPBE)
with the levels of neutralising antibody consistent with protection
in animal models (not shown).
4. Discussion
A new genetic design has been investigated as a robust platform
technology for theefﬁcientproductionof emptyFMDVcapsids. Pre-
vious approaches to recombinant picornavirus particle synthesis
in insect cells have included the expression of the complete picor-
naviruses genomes (Brautigam et al., 1993; Rosen et al., 1993) as
well as co-expression of only the structural precursor protein P1
(or P1-2A) and protease, but the levels of capsid obtained have
been variable (Cao et al., 2010; Ko et al., 2005; Li et al., 2008, 2011;
Oem et al., 2007; Roosien et al., 1990). A systematic analysis of the
causes of the observed variation is not available although the lower
pH of insect cell media is not a major factor (Medina et al., 1995).
FMDV 3C enzymes have a reportedwide range of cellular targets in
addition to the virus P1-2A structural protein precursor suggesting
that host protein cleavage could occur in insect cells to effectively
curtail expression over the 2–4days of a baculovirus infection. A
reduced level of 3C was anticipated to be sufﬁcient to enable P1-
2A cleavage but be insufﬁcient to cause general toxicity. Bicistronic
vectors, in which the 3C coding sequence is transcribed from a less
active promoter have been encouraging but were dependent on
host cell factors (Chung et al., 2010) suggesting that other meth-
ods of translational control, for example through the use of IRES
or frameshift elements (Probst, 2002; Royall et al., 2004) might
be usefully applied. Combining structure-based amino acid sub-
stitutions in a ﬂap that folds over the substrate binding pocket of
3C (Sweeney et al., 2007; Zunszain et al., 2010), with the intro-
duction of a frameshift signal between the P1-2A and 3C coding
regions designed to lower the level of 3C translated rescued cap-
sid protein expression. The well characterised HIV-1 frameshift
(Dinman, 2012) has a measured -1 shift rate of about ∼1:20 in
mammalian cells suggesting 3C levels would be reduced to 5% of
those associated with the in-frame P1-2A-3C cassette. However,
as the rate of frameshift in insect cells has not been measured
directly, the actual amount of 3C expression remains to be deter-
mined. It is noteworthy that the -ribbon modiﬁed here was also
observed in other recent 3C enzyme structures (Cui et al., 2011; Lu
et al., 2011; Norder et al., 2011) indicating that similar strategies
to reduction in 3C activity may be usefully applied to the synthesis
of other picornavirus empty capsids. Similarly, frameshifting rates
may be altered throughmodiﬁcation of the “slippery sequence” on
which the ribosome shifts register (Wilson et al., 1988), suggest-
ing further optimisation may be feasible. The expression strategy
shown here for the FMDV A serotype has also been successful for
O and SAT2 serotypes in preliminary experiments (not shown)
C. Porta et al. / Journal of Virological Methods 187 (2013) 406–412 411
Fig. 5. Antigenic characterisation of recombinant FMDV capsids. Comparison of serotype A22 Iraq native antigen and recombinant A22 empty capsids (solid/grey bars) in a
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Cwin site ELISA with a panel of serum samples. The sera are from animals vaccinated
nd challenged with A Iran96 (13–18), infected with A22 Iraq 24/64 (19, 20), infecte
27, 28) and vaccinated with A Iran05 (29–38). PI – percentage inhibition.
mplying that the technology may be generally applicable to all
erotypes and offer a choice of cell line for scale-up. Empty FMDV
apsids were visually uniform by TEM and antigenically indistin-
uishable fromauthentic virus in twin site ELISA. Empty capsids are
n attractive vaccine candidate for FMDV not only because they do
ot require high biological containment facilities but also because
hey allow modiﬁcation to capsid sequences that would render
nfectious virus nonviable. Thus capsid engineering, for example
or improved stability, broadened immune response (Tobin et al.,
008) or DIVA (Differentiating Infected from Vaccinated Animals)
ompliance may be feasible using the technology described.
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